Suppr超能文献

胆囊癌手术切除的评估,特别提及肝切除

Appraisal of surgical resection of gallbladder carcinoma with special reference to hepatic resection.

作者信息

Paquet K J

机构信息

Department of Surgery, University of Bonn, D-53127 Bonn Heinz Kalk-Hospital, D-97688 Bad Kissingen and Johanniter-Hospital, D-39576 Stendal, Germany.

出版信息

J Hepatobiliary Pancreat Surg. 1998;5(2):200-6. doi: 10.1007/s005340050034.

Abstract

Carcinoma of the gallbladder a gastrointestinal malignancy with an extraordinarily poor prognosis. However, aggressive surgery, with special reference to hepatic resection, may improve survival. To prove this, we performed a retrospective analysis over an 18-year period to investigate the experience of a center that began employing liver resection in patients with gallbladder cancer in 1978. The analysis was based on patients' documentation and regular follow-up to January 1996. The standard procedures were extended cholecystectomy (cholecystectomy with lymphadenectomy and wedge hepatic resection), anatomic segmentectomy of segments IVa and V, and extended hepatectomy. Significance was assessed by the log-rank test. Thirty-nine patients were resected, curatively in 41% (n = 22; group I) and palliatively in 31% (n = 17; group 2). In 28% (n = 15; group 3) a palliative or no operation was performed. Only curatively resected patients were analyzed and followed up to January 1996. No patients in group 1 died postoperatively. The actuarial 5-year survival rate of the patients with curative resection was 55%. Four patients had stage I, two had stage II, four had stage III, and two had stage IV disease according to TNM-classification. Six of the 16 patients without lymph node metastasis survived more than 5 years. A significant difference in long-term survival was recognised between stage II and stage IV patients and between stage (pT1a)- and (look table 1b) (pT1b)-patients (P < 0.01). Diagnostic efforts should focus on detecting early stages I and II gallbladder cancer. In advanced cases, aggressive surgery, particularly with hepatic resection, is the method of choice and is successful even in patients 70 years and older.

摘要

胆囊癌是一种预后极差的胃肠道恶性肿瘤。然而,积极的手术治疗,尤其是肝切除术,可能会提高生存率。为了证实这一点,我们进行了一项为期18年的回顾性分析,以调查一个自1978年起开始对胆囊癌患者采用肝切除术的中心的经验。该分析基于患者的病历记录以及截至1996年1月的定期随访。标准手术包括扩大胆囊切除术(胆囊切除加淋巴结清扫和楔形肝切除)、IVa和V段的解剖性节段切除术以及扩大肝切除术。采用对数秩检验评估显著性。39例患者接受了手术,其中41%(n = 22;第1组)为根治性切除,31%(n = 17;第2组)为姑息性切除。28%(n = 15;第3组)患者接受了姑息性手术或未进行手术。仅对根治性切除的患者进行分析并随访至1996年1月。第1组患者术后均未死亡。根治性切除患者的精算5年生存率为55%。根据TNM分类,4例患者为I期,2例为II期,4例为III期,2例为IV期。16例无淋巴结转移的患者中有6例存活超过5年。II期和IV期患者之间以及(pT1a)期和(见表1b)(pT1b)期患者之间的长期生存率存在显著差异(P < 0.01)。诊断工作应着重于检测早期I期和II期胆囊癌。在晚期病例中,积极的手术治疗,尤其是肝切除术,是首选方法,甚至对70岁及以上的患者也能取得成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验